問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Digestive System Department

Division of General Internal Medicine

更新時間:2023-09-19

高嘉宏Kao, Jia-Horng
  • Principal Investigator
  • Clinical Trial Experience (year) 23 years 9 個月

Highlights

1. Great contribution to DAA drug development for HCV
2. Early phase drug development for HBV treatment
3. Early phase drug development for HCC treatment
4. Early phase drug development for NASH treatment

Study Area

  • Viral Hepatitis
  • Nonalcoholic Steatohepatitis (NASH)
  • Liver disease and Liver cancer

Professional Experiences

National Taiwan University Hospital

Vice Superintendent

-

2020- 迄今

National Taiwan University

Distinguished Professor

Graduate Institute of Clinical Medicine, College of Medicine

2006- 迄今

National Taiwan University

Professor

Graduate Institute of Clinical Medicine, College of Medicine

2003- 迄今

The Gastroenterological Society of Taiwan (GEST)

Executive Director

-

2012- 迄今

National Taiwan University Hospital

Attending Physician

Division of Gastroenterology, Department of Internal Medicine

1992- 迄今

Department of Life Sciences, Ministry of Science and Technology, Taiwan

Chair

Domain of Digestive Diseases

2020- 迄今

APASL (Asian Pacific Association for the Study of the Liver)

Steering Council

-

2012- 迄今

JGH foundation

Trustee

-

2013- 迄今

WGO Hepatology Interest Group

Member

-

2013- 迄今

Advancing Clinical Treatment of Liver Disease (ACT-LD)

Director

-

2011- 迄今

American Association for the Study of Liver Diseases (AASLD)

Academician

-

2015- 迄今

American Association for the Study of Liver Diseases (AASLD)

Asia Pacific Regional Advisory Council

-

2018- 迄今

Journal of the Formosan Medical Association (JFMA)

Chief Editor

-

2017- 迄今

Education

National Taiwan University

Graduate Institute of Clinical Medicine, College of Medicine

Ph.D.

1991-1994

National Taiwan University

School of Medicine, College of Medicine

M.D.

1980-1987

Clinical Trials List

See All106Cases

2016

Total 106

  • I 7

  • I/II 2

  • II 37

  • II/III 1

  • III 48

  • IV 1

  • Others 10

Number of Studies by Scale

11件

Taiwan Multiple Center

Taiwan Single Center

1Cases

Taiwan Multiple Center

11Cases

Multi-Regional Multi-Center

95Cases